Transforming Protein Myb (AA 119-135) Antikörper
Kurzübersicht für Transforming Protein Myb (AA 119-135) Antikörper (ABIN6294290)
Target
Reaktivität
Wirt
Klonalität
Applikation
-
-
Bindungsspezifität
- AA 119-135
-
Verwendungszweck
- Mouse anti-Human c-Myb Antibody [Sodium Azide Free]
-
Spezifität
- Nuclear
-
Aufreinigung
- Amino acids 119-135 (RRKVEQEGYPQESSKAG) from the human protein were used as the immunogen for this c-Myb antibody.
-
Immunogen
- Amino acids 119-135 (RRKVEQEGYPQESSKAG) from the human protein were used as the immunogen for this c-Myb antibody.
-
-
-
Applikationshinweise
-
Flow Cytometry: 0.5-1 μg/million cells in 0.1ml
Immunofluorescence: 1-2 μg/mL -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- In 1X PBS, BSA free, sodium azide free
-
Konservierungsmittel
- Azide free
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- 2-8°C. The azide-free format should be aliquoted and stored at -20°C or colder.
-
-
- Transforming Protein Myb
-
Hintergrund
-
Target Description: The highly leukemogenic avian retrovirus E26 contains two oncogenes, v-Myb and v-Ets, which are expressed together as a fusion protein. The cellular homolog of v-Myb, designated c-Myb, encodes a transcription factor. Deletion or disruption of a negative regulatory domain mapping within the carboxy-terminal domain of c-Myb results in enhanced transactivating capacity and in parallel, leads to activation of its ability to transform hemopoietic cells. c-Myb is expressed preferentially, but not exclusively, in immature hemopoietic cells and its expression decreases as cells differentiate.
Gene Symbol: V-MYB
-
UniProt
- P01104
Target
-